Newsom Keeley D, Holohan Mary M, Eigsti Megan, Patel Payal P, Locke Hannah M, Hadad Ivan
Division of Plastic Surgery, Department of Surgery, University of California School of Medicine, San Diego, La Jolla, California, USA.
Division of Plastic Surgery, Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Transgend Health. 2025 Jun 5;10(3):279-286. doi: 10.1089/trgh.2022.0225. eCollection 2025 Jun.
Many transmasculine patients undergo gender-affirming mastectomy and hysterectomy. Conflicting evidence exists whether these procedures may be safely combined. The purpose of this study is to compare post-operative complications between transmasculine patients who underwent mastectomy alone versus mastectomy in combination with hysterectomy.
Retrospective chart review was performed on patients who underwent mastectomy between January 2020 and September 2022 (=227). Patients were separated into two groups based on whether they had mastectomy alone (=187) versus in combination with hysterectomy (=40). Outcomes included operation time, length of inpatient hospital stay, chest wall complication, and revision rate and gynecologic complication rate. Independent -tests, Pearson-chi square analyses, and Fischer's exact tests were used to compare outcomes between the groups.
Overall rate of chest wall complications was 8.8%. Combination of mastectomy with hysterectomy within the same day significantly increased operation time (311 vs. 166 min, <0.001), admission time (0.23 vs. 0.02 days, <0.001), and rate of chest wall complications (17.5% vs. 6.9%, odds ratio [OR]=2.84 95% confidence interval [CI]: 1.05-7.65), particularly infection (7.5% vs. 1.1%, OR=7.50 95% CI: 1.21-46.46). There was no difference in hematoma or seroma formation, dehiscence, partial or complete nipple loss, or revision rates between groups. Gynecologic complication rate was 2.5% (=1).
Combining mastectomy and hysterectomy is not a benign undertaking as it is associated with increased risk of post-operative chest wall infection. Multidisciplinary surgical teams treating transmasculine patients should choose a surgical plan that optimizes patient outcomes.
许多跨性别男性患者会接受性别确认乳房切除术和子宫切除术。关于这些手术是否可以安全地联合进行,存在相互矛盾的证据。本研究的目的是比较单纯接受乳房切除术的跨性别男性患者与接受乳房切除术联合子宫切除术的患者术后并发症情况。
对2020年1月至2022年9月期间接受乳房切除术的患者(=227例)进行回顾性病历审查。根据患者是单纯接受乳房切除术(=187例)还是接受乳房切除术联合子宫切除术(=40例)将患者分为两组。观察指标包括手术时间、住院时间、胸壁并发症、修复率和妇科并发症发生率。采用独立样本t检验、Pearson卡方分析和Fisher精确检验来比较两组之间的观察指标。
胸壁并发症的总体发生率为8.8%。在同一天进行乳房切除术联合子宫切除术显著增加了手术时间(311分钟对166分钟,<0.001)、住院时间(0.23天对0.02天,<0.001)和胸壁并发症发生率(17.5%对6.9%,优势比[OR]=2.84,95%置信区间[CI]:1.05 - 7.65),尤其是感染(7.5%对1.1%,OR=7.50,95% CI:1.21 - 46.46)。两组之间在血肿或血清肿形成、裂开、部分或完全乳头丢失或修复率方面没有差异。妇科并发症发生率为2.5%(=1例)。
联合进行乳房切除术和子宫切除术并非无害,因为它与术后胸壁感染风险增加有关。治疗跨性别男性患者的多学科手术团队应选择优化患者治疗效果的手术方案。